Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen | Zendy

Kutluk Oktay | Zendy; Erkan Büyük | Zendy; Owen Davis | Zendy; I. S. Yermakova | Zendy; Lucinda L. Veeck | Zendy; Zev Rosenwaks | Zendy

Open Access

Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen

Author(s) -

Kutluk Oktay,

Erkan Büyük,

Owen Davis,

I. S. Yermakova,

Lucinda L. Veeck,

Zev Rosenwaks

Publication year - 2003

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/deg045

Subject(s) - fertility preservation , breast cancer , tamoxifen , gynecology , infertility , medicine , embryo transfer , menstrual cycle , estrogen , fertility , cancer , obstetrics , embryo , pregnancy , biology , population , hormone , environmental health , genetics , microbiology and biotechnology

Breast cancer chemotherapy commonly causes premature ovarian failure and infertility. Because increased estrogen levels are thought to be potentially risky in breast cancer patients, natural cycle IVF (NCIVF) has been used to preserve fertility and treat infertility in these women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research